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Abstract
Background: Matrix metalloproteinases (MMPs) 2 and 9 are two gelatinase members which have been found
elevated in exudative pleural effusions. In endothelial cells these MMPs increase paracellular permeability via the
disruption of tight junction (TJ) proteins occludin and claudin. In the present study it was investigated if MMP2
and MMP9 alter permeability properties of the pleura tissue by degradation of TJ proteins in pleural mesothelium.
Results: In the present study the transmesothelial resistance (RTM) of sheep pleura tissue was recorded in Ussing
chambers after the addition of MMP2 or MMP9. Both enzymes reduced RTM of the pleura, implying an increase in
pleural permeability. The localization and expression of TJ proteins, occludin and claudin-1, were assessed after
incubation with MMPs by indirect immunofluorescence and western blot analysis. Our results revealed that
incubation with MMPs did not alter neither proteins localization at cell periphery nor their expression.
Conclusions: MMP2 and MMP9 increase the permeability of sheep pleura and this finding suggests a role for
MMPs in pleural fluid formation. Tight junction proteins remain intact after incubation with MMPs, contrary to
previous studies which have shown TJ degradation by MMPs. Probably MMP2 and MMP9 augment pleural
permeability via other mechanisms.
Background
Matrix metalloproteinases (MMPs) 2 and 9 are two
gelatinase members which have been measured and
found to be elevated in pleural exudates of different ori-
gin (parapneumonic, malignant, tuberculous). MMPs
consist a family of proteolytic enzymes that break down
virtually all the protein components of the extracellular
matrix. The balance between matrix deposition and
degradation is tightly regulated in human tissues and a
disruption of this balance has been implicated in several
pathological conditions such as cancer, cardiovascular
diseases and arthritis [1,2]. MMP2 and MMP9 are
thought to be involved in pleural fluid accumulation in
the pleural cavity. The disruption of the integrity of the
mesothelial layer or the underlying basement membrane,
and therefore the facilitation of fluid influx into the
pleural space has been proposed as a possible mechan-
ism [3], although no study has been so far conducted.
MMPs have been correlated with the induction of
increased capillary permeability in several inflammatory
conditions, such as brain and myocardium ischemia
injury and diabetic retinopathy [4-6]. In in vitro studies
of endothelial cells, MMPs increase paracellular perme-
ability by disrupting tight junction barrier [5,7,8]. Tight
junctions (TJs) are a specific type of cell-cell contacts
that obstruct paracellular pathway for solute diffusion
and they regulate the paracellular passage of small
molecules such as water and ions [9]. The two major
constituent proteins of TJs are occludin and claudin
and the disruption of these proteins in several culture
systems has been correlated with increased water and
solute flux [9].
This study was designed in order to investigate if
MMP2 and MMP9 increase the permeability of sheep
pleura and thus contribute to the pathogenesis of
pleural effusion formation. The effect of MMP2 and
MMP9 on TJ proteins occludin and claudin-1 was
examined in order to investigate if MMPs alter paracel-
lular permeability of the mesothelial layer.
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MMP2 and MMP9 decrease the transmesothelial
resistance of parietal and visceral sheep pleura
We treated parietal and visceral sheep pleura specimens
with increasing doses of MMP2 and MMP9 (0.1, 1, 10
and 20 ng/ml) and the RTM was measured over a 40-
min period. The RTM decreased in all concentrations
studied and this decrease occurred at both parietal and
visceral pleura and on both the apical and basolateral
side. The decline in RTM suggests for an increase in the
permeability of the tissue. As control RTM , we regarded
the RTM o ft h et i s s u eb e f o r eM M Pw a sa d d e d .T h e
mean RTM of parietal pleura was calculated to be 15 ± 3
Ωcm
2 and that of visceral pleura 17 ± 4 Ωcm
2. Sheets
of pleura specimens, at which no MMPs where applied,
s h o w e das t a b l ev a l u eo fR TM at least for a period of 40
min (Figures 1 and 2, control experiments).
A time-dependent response occurred both apically and
basolaterally for all four concentrations studied. After
the addition of MMPs, the RTM decreased significantly
and declined progressively thereafter up to the 40 min
of incubation when the experiment was terminated
(Figures 1 and 2). A significant drop in resistance
occurred within 5-15 min for both concentrations 0.1
(Figure 1) and 20 ng/ml (Figure 2). However a delayed
response was observed when 0.1 ng/ml MMP2 was
incubated with the apical side of the visceral membrane
(Figure 2b). The effect of 0.1 ng/ml MMP2 on the apical
side of the parietal pleura was not significant (Figure
1a). The changes in RTM for concentrations 1 and 10
ng/ml were comparable to these for 0.1 and 20 ng/ml
(data not shown).
A dose-dependent response was observed for both
MMPs studied (Figure 3): for MMP2 the decrease in
RTM was greatest on the apical side of parietal pleura at
concentration 20 ng/ml (45 ± 12% of the control value).
For MMP9 the greatest effect was observed on the baso-
lateral side of the parietal pleura at the low concentra-
tion of 0.1 ng/ml (59 ± 17% of the control value).
TIMP2 partially prevented the decrease in RTM induced by
MMPs
Next, the MMP inhibitor TIMP2 (200 ng/ml) was
applied to the pleura either alone or simultaneously
Figure 1 Effect of 0.1 ng/ml MMP2 and MMP9 on the transmesothelial resistance (RTM) of sheep pleura. A time-dependent decrease in
transmesothelial resistance (RTM) occurred at both parietal and visceral pleura and on both the apical and basolateral side. For MMP2 the
decrease on the apical side of parietal pleura is not significant. Data are given as mean ± SD (n = 6). ns: non-significant, * p < 0.05, ** p < 0.001
and *** p < 0.0001 compared to control RTM (ANOVA test with Dunett post-test).
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concentration 0.1 ng/ml. These concentrations of
MMPs were chosen because of their maximum effect on
RTM. TIMP2 was shown to partially prevent the MMP2
(Figure 4) and MMP9-induced (Figure 5) fall in RTM.
This effect was obvious on both the parietal and visceral
pleura. Moreover, the application of TIMP2 by itself
tended to increase pleural permeability, particularly at
visceral pleura and at its basolateral side, as the RTM
was 50 ± 5% of control value on the 40
th min (Figure
5d).
MMP2 or MMP9 do not alter occludin and claudin-1
immunostaining at cell cultures
We next investigated if the increase in transmesothelial
permeability, as occurred by Ussing chamber experi-
ments, is accompanied by loss of tight junction proteins
by indirect immunofluorescence. The mesothelial cells
in control experiments showed a clear membrane pat-
tern for occludin (Figure 6) and claudin-1 staining (Fig-
ure 7). The staining was continuous and decorated the
cell periphery. Because cells were well grown to
confluency and occludin and claudin-1 are located at
sites of lateral membrane with cell-cell contact, a con-
tinuous line resembling to “honeycomb” pattern was
obvious. Non-specific staining of the nucleus occurred.
The incubation of mesothelial cells with MMPs had no
effect on occludin and claudin-1 immunostaining (Fig-
ures 6 and 7, respectively), implying that MMPs do not
alter occludin and claudin-1 localization at tight
junctions.
MMP2 or MMP9 do not alter occludin and claudin-1
expression at mesothelial cells
Western blotting of mesothelial cell extracts showed no
alteration for occludin and claudin-1 staining (Figure 8).
Occludin migrated as two main bands with apparent
molecular weights from 60 to 65 KDa. An additional
band at about 85 KDa was also detected (Figure 8a).
Claudin-1 was detected as a 28 kDa band (Figure 6b).
Neither loss of band intensity nor the appearance of
new protein fragments was observed. These findings
imply that MMP2 and MMP9 do not degrade TJ
proteins.
Figure 2 Effect of 20 ng/ml MMP2 and MMP9 on the transmesothelial resistance (RTM) of sheep pleura. A time-dependent decrease in
transmesothelial resistance (RTM) of sheep pleura occurred after the addition of MMP2 or MMP9 at concentration 20 ng/ml. The time-dependent
response occurred at both parietal and visceral pleura and on both the apical and basolateral side. Data are given as mean ± SD (n = 6). ns:
non-significant, * p < 0.05, ** p < 0.001 and *** p < 0.0001 compared to control RTM (ANOVA test with Dunett post-test).
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Page 3 of 11Figure 3 Dose-dependent decrease in transmesothelial resistance (RTM) of sheep pleura after the addition of MMP2 or MMP9. Different
concentrations (0.1, 1, 10 and 20 ng/ml) of MMP2 and MMP9 were added at parietal and visceral pleura and on the apical and basolateral side
and the RTM was measured on the 40 min. The changes in RTM are expressed as percentage difference of the control value (100%), which is the
RTM value just before the addition of MMP. Data are given as mean ± SD (n = 6). ns: non-significant, * p < 0.05, ** p < 0.001 and *** p < 0.0001
compared to control RTM (paired t-test).
Figure 4 TIMP2 reverses partially the effect of MMP2 on pleural permeability. TIMP2 was added at concentration 200 ng/ml at on the
apical and basolateral side of parietal(a) and visceral(b) pleura. MMP2 was added at the same time at concentration 20 ng/ml. TIMP2 seems to
prevent partially the decline in RTM induced by MMP2 on the 40
th minute of the experimental procedure. Data are given as mean ± SD. n = 6
for MMP2, n = 3 for combined MMP2 and TIMP2, n = 3 for TIMP2.
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In the present study MMP2 and MMP9 decreased the
transmesothelial resistance of parietal and visceral sheep
pleura in in vitro experiments. This decrease supports
that MMPs augment pleural mesothelial permeability.
The paracellular pathway, through which mesothelial
permeability may increase, was studied. After incubation
of primary mesothelial cells with MMP2 or MMP9,
mesothelial monolayer integrity was not disrupted and
the expression of TJ proteins occludin and claudin-1 in
the cytoplasmic membrane remained intact.
MMP2 and MMP9 were selected for our study
because they have been found elevated in exudative
pleural effusions of different origin [3,10,11]. MMP2 is
expressed and secreted constitutively in the pleural cav-
ity by mesothelial cells [12]. In exudates high levels of
MMP2 may be due to increased expression as a result
of stimulation of mesothelial cells by cytokines or other
cells, such as mononuclear cells, might collaborate in
MMP2 release [10]. MMPs can degrade almost all com-
ponents of the extracellular matrix (ECM) and to date it
is widely known that MMPs can cleave not only ECM
components, such as collagen and elastin, but also non-
ECM protein substrates, such as cell surface molecules,
ECM-bound growth factors and cytokines released on
the ECM [13,14].
In the present study the decrease in transmesothelial
electrical resistance of sheep pleura that occurs after
incubation with MMP2 or MMP9 suggests for an
increase in the permeability of the pleura. As expected
for an enzyme, the decrease in resistance of the pleura
was time-dependent with the maximum decline in resis-
tance occurring on the 40 min. Regarding the dose-
dependent effect, a remarkable difference between
MMP2 and MMP9 occurred: for MMP2 the greatest
increase in permeability occurred at the highest concen-
tration studied, which is 20 ng/ml. On the contrary, for
MMP9 the greatest increase in permeability occurred at
the lowest concentration studied, which is 0.1 ng/ml.
The reason for this discrepancy is not elucidated but we
should take into account differences between enzyme
kinetics and substrate specificity.
TIMP2 is a tissue inhibitor of metalloproteinases and
inhibits MMPs activity by binding noncovalently to their
active site [15]. TIMP2 is found in exudates whereas in
transudates its levels are usually no detectable [3]. The
application of TIMP2 on the pleura inhibited the
decrease in RTM which was induced by MMPs on both
the parietal and visceral pleura. This finding enhances
our previous finding and suggests that the decline in
RTM is an effect caused by MMPs and not a non-pecific
result. TIMP2 was selected at the present study because
it is 2-9 times more effective than TIMP1 for the inhibi-
tion of MMP2 and MMP9 activity [16]. Moreover,
TIMP2 tended to increase pleural permeability particu-
larly at visceral pleura and at its basolateral side, when
it was applied alone at the pleura. This finding can be
interpreted considering the growth-promoting-activity
that has been attributed to TIMP2 [17]. A wide range of
human, bovine and mouse cells proliferate when incu-
bated with TIMP2. Indeed, receptors of TIMP2 have
been identified at the surface of the above cells [18].
O n ep o s s i b l ee x p l a n a t i o ni st h a tT I M P 2a c t so n
mesothelial cells via receptor-binding and influences
mesothelial permeability, as is the case for numerous
growth factors.
We next looked for a possible mechanism explaining
the impact of MMPs on the transmesothelial resistance
and asked whether TJ proteins, occludin and claudin-1,
m a yb eh y d r o l y z e db yM M P s .T J sa r eas p e c i f i ct y p eo f
cell-cell contact which are located in the most apical
region of the lateral plasma membrane. The paracellular
passage of small molecules, such as water and solutes, is
highly regulated by the TJ proteins, including occludin
Figure 5 TIMP2 reverses partially the effect of MMP9 on pleural permeability. TIMP2 was added at concentration 200 ng/ml on the apical
and basolateral side of parietal(a) and visceral pleura(b). MMP9 was added at the same time at concentration 0.1 ng/ml. TIMP2 seems to prevent
partially the decline in RTM induced by MMP9 on the 40
th minute of the experimental procedure. Data are given as mean ± SD. n = 6 for MMP9,
n = 3 for combined MMP9 and TIMP2, n = 3 for TIMP2.
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ments for occludin and claudin-1 showed a continuous
staining at cell periphery which was not weakened and
remained at the cell borders after incubation with
MMPs. Similarly, western blot revealed that these pro-
teins are expressed at pleural mesothelium under
normal conditions and are not proteolytically disrupted
by MMPs. More specifically for occludin, western blot
analysis revealed three distinct bands: at 60 KDa, 85
KDa and a broad band at about > 60 KDa. These bands
m a yb ed u et oo c c u r r e n c eo fs p l i c ev a r i a n t so rp o s t -
transational modification, i.e phosphorylation. Previous
Figure 6 Immunofluorescent microcopy of pleural mesothelial cells treated or not with MMP2 and MMP9 using an anti-occludin
antibody. Both control cells and cells treated with MMP2 or MMP9 displayed a continuous staining at cell periphery. Nuclei were stained with Dapi.
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Page 6 of 11Figure 7 Immunofluorescent microcopy of pleural mesothelial cells treated or not with MMP2 and MMP9 using an anti-claudin-1
antibody. Control cells displayed a continuous staining at cell periphery. The same pattern occurred also for cells treated with MMP2 or MMP9.
Nuclei were stained with Dapi.
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lated on serine and threonine resides and modulation of
occludin phosphorylation regulates cellular localization
and paracellular permeability [19,20]. Some degree of
phosphorylation may also be the case in the present
study. As far as the 80 KDa band is concerned, we can-
not rule out the possibility that this band corresponds
to a protein complex between occludin and claudin
(MWs 60 and 28 KDa respectively). Occludin and clau-
din do not interact directly to each other, but they
crosslink by integral TJ proteins, such as ZO-1, ZO-2
and ZO-3 [9]. The intensity of the above band increased
after MMPs incubation, implying that MMPs interfere
with occludin and claudin interactions. Because the 80
KDa band appeared enhanced to all three western blot
experiments that were performed, it is less likely to
represent an artifact. The mesothelial cells used for
immunofluorescence and western blotting derived from
upper-, middle- and lower-heighted visceral pleura and
no difference between them occurred.
Our data is contradictory to previous results which
have revealed MMPs as major contributors to the con-
trol of paracellular permeability by proteolytic degrada-
tion of TJ proteins. More specifically, MMPs have been
correlated with an increase in capillary permeability that
follows ischemia-reperfusion injury in brain [8], in myo-
cardium [4], in lung [21] and in kidney [22]. These stu-
dies attributed to MMPs an elementary role in the
inflammatory process and the breakdown of the paracel-
lular capillary permeability during inflammation. In
some studies a selective cleavage of TJ proteins occurred
[7,23] but the results of our study clearly showed that TJ
integrity is not disrupted at mesothelial cells by MMPs.
It is possible that other substrates, different from occlu-
din and claudin-1, are a molecular target for MMPs at
pleural mesothelium. For example, MMPs have been
found to disrupt or reorganize the basement membrane
of endothelial cells and thus result to increased perme-
ability [24,25]. Moreover, adherent junctions are also
degraded by MMPs and their hydrolysis leads to TJ dis-
assembly and to increased permeability [22,26].
The limitations of the present study are the followings:
Firstly, the Ussing chamber technique investigates per-
meability alterations provoked on mesothelial mem-
brane, which consists a confluent membrane between
the apical and basolateral compartment of a chamber.
However, under in vivo conditions it is possible that
MMPs act not only on mesothelial cells but also on vas-
cular capillaries lying beneath the basement membrane.
Secondly, the precise role of the mesothelial layer at
pleural fluid turnover is not fully established. Although
we used to believe that mesothelial cells are leaky and
d i s p l a yn or e s i s t a n c ea tp l e u r a lf l u i dp a s s a g e ,m o r e
recent investigations indicate that the permeability to
s o l u t e so fm e s o t h e l i u mi so ft h es a m eo r d e ro fm a g n i -
tude as that of the capillary endothelium [27,28]. This
means that pleural fluid is a filtrate of pleural capillaries
and mesothelium too. Moreover, damage of pleural
mesothelial monolayer by lipopolysaccharide (LPS),
thrombin and bacteria increase pleural permeability to
proteins and demonstrate to play a central role in the
formation of effusions [29,30]. Finally, sheep pleura
resembles to human pleura as far as morphology and
function is concerned. On both pleurae the blood supply
Figure 8 Immunoblot analysis of TJ proteins after treatment with MMPs. Occludin appears as a 65 KDa protein (a) and claudin-1 migrates
as a 28 KDa band (b). lane 1 = control, no incubation, lane 2 = control, incubation for 1 h at 37°C, lane 3 = incubation with MMP2 for 1 h at
37°C, lane 4 = incubation with MMP9 for 1 h at 37°C. Equal amounts of protein were loaded to each lane (15 μg protein/lane). Antibody against
b-actin was used to control the equal amounts of proteins in the lysates (c). No alteration to the tight junction proteins occludin and claudin-1
was observed after incubation with MMPs.
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two different types of mesothelial cells are found: the
cyboidal cells with less developed TJs and flattened cells
with more TJs [31]. However, further studies should be
performed at human pleura in order to confirm the
results of the present study.
Our findings imply an important role for MMPs in the
pathogenesis of pleural effusions. Under normal condi-
tions, MMPs and especially MMP2 are found only in
small amounts in the pleural fluid. The balance of
MMPs in pleural fluid may serve the degradation and
turnover of ECM that underlies mesothelial cells and
which normally occurs in low rates. However in pleural
exudates MMP2 and MMP9 levels increase, as shown
from previous studies, and a role for MMP2 and MMP9
in pleural fluid formation is proposed by our study.
Tight junctions do not apparently loosen in mesothelial
cells after the addition of MMPs. It is possible that
other mechanisms exist through which MMPs increase
mesothelial permeability. The revelation of the mechan-
ims by which MMPs compromise the mesothelial bar-
rier will provide a better understanding of the
pathogenesis of pleural fluid formation.
Methods
Specimen collection and preparation of sheep pleura
Intact sheets of visceral and parietal sheep pleura were
obtained from adult female sheep. The samples were
collected from the slaughterhouse immediately after the
death of the animals (time of warm ischemia close to 0
minutes). Pieces of parietal pleura were carefully
stripped from the chest wall whereas those of visceral
pleura were carefully stripped from the underlying lung.
Parietal and visceral pleura were examined for evidence
of holes or adherent tissue and were discarded if they
were not intact. Immediately after removal, the pleural
tissue from the animals was placed in oxygenated
Krebs-Ringer bicarbonate (KRB) solution at 4°C and
transferred to the laboratory within 30 minutes. The
KRB solution was balanced at pH 7.4 and bubbled with
95%O2-5%CO2. The solution contained (in mM) 117.5
NaCl, 1.15 NaH2PO4, 24.99 NaHCO3,5 . 6 5K C l ,
1.18MgSO4, 2.52 CaCl2, and 5.55 glucose.
Electrophysiological transmesothelial measurements
The effect of MMPs on pleural permeability was studied
by conducting Ussing experiments under open circuit
conditions. The pleura was mounted carefully in Ussing
chambers (K Mussler Scientific Instruments, Aachen,
Germany) with an opening surface area of 1 cm
2.T i s -
sues were bathed with 4 ml KRB solution on each side
of the membrane and were continuously oxygenated
with 95%O2-5%CO2. Two pairs of Ag/AgCl electrodes
monitored the transmesothelial potential difference (Pd,
in mV) and the transmesothelial resistance (RTM,i n
Ωullet cm
2) under open circuit conditions.
Transmesothelial electrical parameters were measured
before and after the addition of active MMP2 or MMP9
(Calbiochem, San Diego, California, USA) at four differ-
ent concentrations 0.1, 1, 10 and 20 ng/ml. In some
experiments TIMP2, a tissue inhibitor of metalloprotei-
nases, was added at concentration 200 ng/ml. MMPs
and TIMP2 were added both apically and basolaterally
and the electrical parameters were monitored over a
period of 40 minutes (at minutes 5, 10, 15, 20, 25, 30,
35, 40). After the addition of the above substances,
alterations in the RTM were expressed as the change
from the starting value. Activity of matrix metalloprotei-
n a s e si st e m p e r a t u r e - d e p e n dent, therefore measure-
ments of transmesothelial electrical parameters were
conducted at 37°C. The mesothelial cell membrane
facing the fluid side is here called the apical membrane,
and that facing the blood side is called the basolateral
membrane. The voltage response to applied current
pulses of 50 μA amplitude and 200 msec duration was
measured. The transmesothelial resistance was calcu-
lated deducting automatically the resistance of the
solution.
Cell cultures
Primary cultures of sheep pleural mesothelial cells were
prepared (modified from Stylianou et al [32]). Briefly,
specimens of intact visceral sheep pleura were obtained
from the slaughterhouse immediately after the death of
the animal. The procedure was performed under sterile
conditions and pieces of approximately 6 cm
2 were
placed in M199 media (Invitrogen, Carlsbad, USA) sup-
plemented with 10% fetal bovine serum (FBS), 100 U/ml
penicillin and 100 μg/ml streptomycin. The specimen
was transferred on ice to the laboratory, washed with
PBS and subjected to enzymatic disaggregation. The
specimen was in this incubated for twenty minutes at
37°C in disaggregation solution that contained 0.125%
trypsin, 0.01% EDTA and 0.1% glucose in PBS solution.
After incubation the pleura membrane was discarded
and the suspension was centrifuged at 100 × g for five
minutes at 4°C. The resultant supernatant was discarded
and the cell pellet was suspended in 10 ml prewarmed
M199 media supplemented with 10% fetal bovine serum
(FBS), 100 U/ml penicillin, 100 μg/ml streptomycin, 0.4
μg/ml hydrocortisone, 10 mg/ml insulin, 50 mg/ml
transferin and 200 mM L-glutamine and subjected to
recentrifugation at 100 × g for five minutes at 4°C.
Finally the supernatant was discarded, the cell pellet was
resuspended in 5 ml of the same medium and seeded in
25 cm
2 tissue culture flasks. The medium was changed
every third or fourth day. Cultures contaminated with
spindle-like cells, representing probably fibroblasts, were
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requisite for their experimental use. Passages 1 and 2
were used for immunofluorescence experiments and
western blot.
Indirect immunofluorescence
For immunofluorescence experiments, mesothelial cells
were grown on fibronectin-coated glass coveslips and
confluency was reached about 7 days later. After two
subsequent washes with PBS, cells were incubated in
serum-free media with MMP2 or MMP9 at concentra-
tion 10 μg/ml for one hour at 37°C and then were fixed
with 3% formaldehyde for 5 minutes at room tempera-
ture. Control cells received no MMP treatment and
were incubated with serum-free media. After washing,
the cells were permeabilized with 1% Triton X-100 in
PBS for 15 minutes at 4°C. Samples were washed with
PBS and soaked in blocking solution, which consisted of
3% BSA and 0.1% Tween-20 in PBS for 16 hours. Cov-
erslips were incubated with polyclonal anti-occludin
(dilution 1:50; Zymed Laboratory, San Fransisco, USA)
or polyclinal anti-claudin-1 antibody (dilution 1:50;
Zymed Laboratory, San Fransisco, USA) in PBS contain-
i n g1 %B S A / 0 . 1 %T w e e n - 2 0f o r1h o u ra tr o o mt e m -
perature. Cells were rinsed three times in 1% BSA/0.1%
Tween-20/PBS and incubated with a FITC- or CY3-con-
jugated anti-rabbit IgG secondary antibody (dilution
1:50), for occludin and claudin repectively, for 30 min-
utes at room temperature. Finally coverslips were
washed and mounted with Vectashield containing Dapi.
Images were collected with a Leica DFC480 camera
(LAS software version V2.3.1R1) on an Axioscope 40
Zeiss microscope.
Western blot
Mesothelial cells were grown in culture dishes and cellu-
lar extract was obtained as described previously by Giebel
et al [5]. Briefly, mesothelial cells were washed with cold
PBS and cellular extract was obtained after scraping the
culture dish with 200 μl lysis buffer (0.1% Triton X-100
in 100 Mm PO4 buffer). The cellular extract was incu-
bated for 30 min on ice and then was subjected to centri-
fugation at 100 × g for 30 min at 4°C. The pellet was
discarded and the supernatant was divided into four
equal aliquots each of which had a volume 20 μl. The
protein concentration was measured by Bradford method
(Bio rad) and each aliquot contained 15 μg proteins. Two
aliquots were used as controls and one of them was incu-
bated at 37°C for one hour. Additional aliquots received
either MMP2 or MMP9 at concentration 5 μg/ml and
were incubated at 37°C for one hour. At the end of incu-
bation period, SDS sample buffer was added to all ali-
quots and incubation at 95°C for 3 min followed.
Samples were loaded on 10% polyacrylamide gel for
electrophoresis and then proteins were transferred to a
nitrocellulose membrane. The quality of the transfer was
controlled by Ponceau staining of the membrane. The
membrane was blocked in 5% milk in PBS-Tween-20 for
30 min at room temperature and then incubated with
primary antibodies (polyclonal anti-occludin and anti-
claudin-1 at dilution 1:250) for 16 hours at 4°C. After 3
washes with PBS-Tween-20, the membrane was incu-
bated for 1 hour at room temperature with HRP-second-
ary antibody (anti-rabbit IgG at dilution 1:3000) and the
immunoreactive bands were detected with enhanced che-
miluminescence (Roche).
Statistical analysis
Statistical analysis for quantative experiments was per-
formed using GraphPad Prism 5. For permeability
experiments, comparisons between control and MMP-
treated tissues were made using one way ANOVA test
with Dunnett post-test. For short-circuit experiments,
the comparison between control experiments and
experiments with application of MMPs was performed
with unpaired t-test. Values of p < 0.05 were regarded
as significant.
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